Literature DB >> 26997346

A social paradigm in psychiatry - themes and perspectives.

S Priebe1.   

Abstract

AIMS: Psychiatry as science is underpinned by paradigms. Considering whether a social paradigm may help to advance the current state of psychiatry, the review provides a reference to the rich, but fragmented past of related initiatives in the history of psychiatry and a personal view of themes, challenges and perspectives of using a social paradigm in psychiatry.
METHODS: Major themes are the evidence on social determinants of mental health; the value-based importance of integrating people with mental disorders in society; options to overcome the social isolation and improve the networks of psychiatric patients; utilising a systemic approach for interventions in families and communities; and understanding group and one-to-one treatments in psychiatry primarily as social interactions. Whilst all these themes open up perspectives for future action and/or research, there are also conceptual challenges through the limitations of the current construct of mental disorders and the dominating terminology.
RESULTS: Initiatives for using a social paradigm in psychiatry may refer to important achievements in the past, but need to go beyond this and consider on-going societal changes.
CONCLUSION: Innovation may benefit from close collaboration with social sciences and humanities.

Entities:  

Keywords:  interactions; mental health care; social constructs; social determinants; social networks; social paradigm; social psychiatry

Mesh:

Year:  2016        PMID: 26997346      PMCID: PMC7137662          DOI: 10.1017/S2045796016000147

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN: 2045-7960            Impact factor:   6.892


  18 in total

1.  Are psychiatrists an endangered species? Observations on internal and external challenges to the profession.

Authors:  Heinz Katschnig
Journal:  World Psychiatry       Date:  2010-02       Impact factor: 49.548

2.  The future of academic psychiatry may be social.

Authors:  Stefan Priebe; Tom Burns; Tom K J Craig
Journal:  Br J Psychiatry       Date:  2013-05       Impact factor: 9.319

3.  Psychiatrist effects in the psychopharmacological treatment of depression.

Authors:  Kevin M McKay; Zac E Imel; Bruce E Wampold
Journal:  J Affect Disord       Date:  2006-02-28       Impact factor: 4.839

4.  Specialty choice in UK junior doctors: is psychiatry the least popular specialty for UK and international medical graduates?

Authors:  Seena Fazel; Klaus P Ebmeier
Journal:  BMC Med Educ       Date:  2009-12-24       Impact factor: 2.463

Review 5.  Therapeutic relationships in psychiatry: the basis of therapy or therapy in itself?

Authors:  Stefan Priebe; Rosemarie Mccabe
Journal:  Int Rev Psychiatry       Date:  2008-12

6.  The effectiveness of supported employment for people with severe mental illness: a randomised controlled trial.

Authors:  Tom Burns; Jocelyn Catty; Thomas Becker; Robert E Drake; Angelo Fioritti; Martin Knapp; Christoph Lauber; Wulf Rössler; Toma Tomov; Jooske van Busschbach; Sarah White; Durk Wiersma
Journal:  Lancet       Date:  2007-09-29       Impact factor: 79.321

7.  Continuum beliefs and stigmatizing attitudes towards persons with schizophrenia, depression and alcohol dependence.

Authors:  Georg Schomerus; Herbert Matschinger; Matthias C Angermeyer
Journal:  Psychiatry Res       Date:  2013-03-05       Impact factor: 3.222

8.  The Effectiveness of a Patient-Centred Assessment with a Solution-Focused Approach (DIALOG+) for Patients with Psychosis: A Pragmatic Cluster-Randomised Controlled Trial in Community Care.

Authors:  Stefan Priebe; Lauren Kelley; Serif Omer; Eoin Golden; Sophie Walsh; Husnara Khanom; David Kingdon; Clare Rutterford; Paul McCrone; Rosemarie McCabe
Journal:  Psychother Psychosom       Date:  2015-08-06       Impact factor: 17.659

Review 9.  Are Group Psychotherapeutic Treatments Effective for Patients with Schizophrenia? A Systematic Review and Meta-Analysis.

Authors:  Stavros Orfanos; Ciara Banks; Stefan Priebe
Journal:  Psychother Psychosom       Date:  2015-05-23       Impact factor: 17.659

10.  Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials.

Authors:  Paolo Fusar-Poli; Evangelos Papanastasiou; Daniel Stahl; Matteo Rocchetti; William Carpenter; Sukhwinder Shergill; Philip McGuire
Journal:  Schizophr Bull       Date:  2014-12-20       Impact factor: 9.306

View more
  7 in total

1.  [Where can psychiatry go from here?]

Authors:  S Priebe
Journal:  Nervenarzt       Date:  2018-11       Impact factor: 1.214

2.  What should we do to promote a social perspective in psychiatry?

Authors:  T Becker; N Rüsch
Journal:  Epidemiol Psychiatr Sci       Date:  2016-07-25       Impact factor: 6.892

3.  "You have to fight to legitimize your existence all the time": The social context of depression in men with physical disabilities.

Authors:  Dena Hassouneh; Kiki Fornero
Journal:  Arch Psychiatr Nurs       Date:  2020-11-26       Impact factor: 2.218

4.  The Lost Social Context of Recovery Psychiatrization of a Social Process.

Authors:  Alain Topor; Tore Dag Boe; Inger Beate Larsen
Journal:  Front Sociol       Date:  2022-04-04

5.  What kind of science for dual diagnosis? A pragmatic examination of the enactive approach to psychiatry.

Authors:  Jonathan Led Larsen; Katrine Schepelern Johansen; Mimi Yung Mehlsen
Journal:  Front Psychol       Date:  2022-07-18

6.  Forty years without mental hospitals in Italy.

Authors:  Corrado Barbui; Davide Papola; Benedetto Saraceno
Journal:  Int J Ment Health Syst       Date:  2018-07-31

7.  Possibilities for the future of global mental health: a scenario planning approach.

Authors:  Stefan Priebe; Álvaro Arenas Borrero; Victoria Bird; Alma Džubur Kulenoviĉ; Domenico Giacco; Carlos Gómez Restrepo; Fahmy Hanna; Sandrasagary Jayacodi; Seggane Musisi; Craig Morgan; Noeline Nakasujja; Alina Sabitova; Stephen Sandford; Nelson Sewankambo; José Miguel Uribe Restrepo
Journal:  BMC Psychiatry       Date:  2019-12-11       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.